(893.5) Hypothalamic Corticotrophin Releasing Hormone Signal Contributes to Elevated Sympathetic Outflow in primary hypertension

Poster Board Number: E388

Hua Zhang (University of Missouri), Jing-Jing Zhou (The University of Texas MD Anderson Cancer Center), Jian-Ying Shao (The University of Texas MD Anderson Cancer Center), Zhaofu Sheng (University of Missouri), Peiru Zheng (University of Missouri), De-Pei Li (University of Missouri)

Corticotropin-releasing hormone (CRH) is a neuropeptide involved in regulating neuroendocrine and autonomic function. CHR mRNA and protein expression in the hypothalamic paraventricular nucleus (PVN) are significantly increased in patients with primary hypertension. However, the role of CRH signals in elevated sympathetic outflow in primary remains unclear. Here, we showed that CRH receptor 1 (CRHR1) protein level rats was significantly increased in the PVN tissue in spontaneously hypertensive (SHR) compared with Wistar-Kyoto (WKY). Upregulated CRHR1 level in the PVN was not significantly affected by lowing arterial blood pressure (ABP) by celiac ganglionectomy in SHRs. Immunocytochemistry staining revealed that CRHR1 immunoreactivities were in PVN neurons projecting to the rostral ventrolateral medulla (RVLM). Bath application of CRH induced a significantly greater increase in the firing rate of PVN-RVLM projection neurons in SHRs than in WKY rats. Blocking CRHRs with astressin or CRHR1 with antalarmin significantly decreased firing rate of PVN-RVLM projection neurons in SHR but not in WKY, while blocking CRHR2 with antisauvagine-30 did not alter the firing rate of these neurons in SHR. Both antalarmin and antisauvagine-30 did not change the frequency and amplitude of miniature inhibitory post-synaptic currents or miniature excitatory post-synaptic currents recorded in brain slice preparation of SHR and WKY rats. In addition, bilateral microinjection of CRH into the PVN produced a greater dose-dependent increases in arterial blood pressure (ABP), renal sympathetic activity (RSNA), and heart rate (HR) in anesthetized SHRs than in WKY rats. Microinjection of CRHR1 antagonist NBI35965 into the PVN significantly reduced basal ABP, RSNA, and HR in SHRs but did not change ABP, RSNA, and HR in WKY rats. These data suggested that the upregulation of CRHR1 in the PVN is critically involved in elevated sympathetic outflow and hyperactivity of sympathetic-related neurons in hypothalamus in primary hypertension.

Supported by grants from National Institutes of Health (HL139523, HL142133, and HL159157).